Grant: Collaborative Health Research Projects
Ryerson University
$161,166.00
Synthesis of Bioactive Augments for use in Revision Knee Joint Replacement
EF 2017-18
Résumé
Damage to the knee can limit activities and cause severe pain in patients. In cases where nonsurgical treatments are nolonger helpful, total knee replacement is often utilized. In 2010-11 there were estimated to have been over 53,000 kneereplacement operations performed in Canada, around 6% of which were revision surgeries. However, the metal implantsused to replace the damaged tissue can lead to post-surgery complications including bacterial infection, wear and/orloosening of the implant. This explains the urgent need to develop disruptive technologies that can not only provide thestructural support of metal, but also promote healing and fight infection.Bioactive glasses and ceramics are candidate materials as they display the ability to bond to bone to promote healing andimplant stability, and can be formulated to have anti-bacterial properties. The proposed collaborative health research projectwill develop a novel glass-ceramic material that can be used, in the first instance, as a tibial augment in revision kneesurgery. The implant will offer structural support and promote healing by fusing with the patients own bone and by havingmechanical properties similar to human bone. The implant will also prevent infection by releasing anti-bacterial ions at thesite of surgery. If successful, this innovative material could also be extended to other joint surgeries including those aroundthe hip and spine.At a time when combined Canadian public and private spending on health care is almost $192B, amounting to 11.7% of totalgross domestic product, such a disruptive technology could revolutionize surgical approaches, reduce the need for revisions,promote considerable savings for the healthcare system and improve quality of life in Canada; crucial as our agingpopulation is expected to further propel health costs upward.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
493838-2016
Name nom
Towler, Mark
Department département
Mechanical and Industrial Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
161166
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Synthesis of Bioactive Augments for use in Revision Knee Joint Replacement
Keyword
NSERC
Application summary
Damage to the knee can limit activities and cause severe pain in patients. In cases where nonsurgical treatments are nolonger helpful, total knee replacement is often utilized. In 2010-11 there were estimated to have been over 53,000 kneereplacement operations performed in Canada, around 6% of which were revision surgeries. However, the metal implantsused to replace the damaged tissue can lead to post-surgery complications including bacterial infection, wear and/orloosening of the implant. This explains the urgent need to develop disruptive technologies that can not only provide thestructural support of metal, but also promote healing and fight infection.Bioactive glasses and ceramics are candidate materials as they display the ability to bond to bone to promote healing andimplant stability, and can be formulated to have anti-bacterial properties. The proposed collaborative health research projectwill develop a novel glass-ceramic material that can be used, in the first instance, as a tibial augment in revision kneesurgery. The implant will offer structural support and promote healing by fusing with the patients own bone and by havingmechanical properties similar to human bone. The implant will also prevent infection by releasing anti-bacterial ions at thesite of surgery. If successful, this innovative material could also be extended to other joint surgeries including those aroundthe hip and spine.At a time when combined Canadian public and private spending on health care is almost $192B, amounting to 11.7% of totalgross domestic product, such a disruptive technology could revolutionize surgical approaches, reduce the need for revisions,promote considerable savings for the healthcare system and improve quality of life in Canada; crucial as our agingpopulation is expected to further propel health costs upward.